PubRank

H Widner

Author PubWeight™ 63.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992 5.51
2 Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990 3.31
3 Neuron-specific enolase correlates with other prognostic markers after cardiac arrest. Neurology 2011 3.15
4 Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 1999 3.06
5 Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999 2.98
6 Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat Med 1995 1.61
7 Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 1994 1.50
8 Discordant neural tissue xenografts survive longer in immunoglobulin deficient mice. Transplantation 1999 1.41
9 Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol 2000 1.30
10 Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997 1.29
11 Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol 1989 1.24
12 Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp Brain Res 1988 1.23
13 Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 2000 1.18
14 Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 1999 1.14
15 Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol 1992 1.13
16 Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat Med 1999 1.06
17 The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) 2005 1.05
18 Can sensory stimulation improve the functional outcome in stroke patients? Neurology 1993 1.04
19 Tracking the neurodegeneration of parkinsonian disorders--a pilot study. Neuroradiology 2007 1.03
20 Clinical rating of dyskinesias in Parkinson's disease: use and reliability of a new rating scale. Mov Disord 1999 1.00
21 Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants. Ann Neurol 1992 0.96
22 Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats. Exp Brain Res 1995 0.96
23 Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc Natl Acad Sci U S A 1994 0.95
24 Fetal dopamine-rich mesencephalic grafts in Parkinson's disease. Lancet 1989 0.88
25 Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease. Acta Neurol Scand 2012 0.86
26 DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease. Neuroscience 1996 0.86
27 Quinolinic acid-induced inflammation in the striatum does not impair the survival of neural allografts in the rat. Eur J Neurosci 1998 0.85
28 Porcine neural xenografts in rats and mice: donor tissue development and characteristics of rejection. Exp Neurol 2001 0.85
29 Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment. Eur Neurol 2005 0.84
30 Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease. Ann N Y Acad Sci 1987 0.83
31 Neural tissue xenotransplantation: what is needed prior to clinical trials in Parkinson's disease? Neural Tissue Xenografting Project. Cell Transplant 2000 0.83
32 Evaluation of long-term functional status in first-ever stroke patients in a defined population. Scand J Rehabil Med Suppl 1992 0.81
33 Immune reactions following systemic immunization prior or subsequent to intrastriatal transplantation of allogeneic mesencephalic tissue in adult rats. Neuroscience 1995 0.81
34 Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: will the second graft be rejected? Neuroscience 1993 0.81
35 Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier. Exp Brain Res 1989 0.81
36 Neural tissue xenografting. Scand J Immunol 2000 0.80
37 Expression of platelet-derived growth factor in and around intrastriatal embryonic mesencephalic grafts. Cell Transplant 1994 0.80
38 Rat intrastriatal neural allografts challenged with skin allografts at different time points. Exp Neurol 1997 0.79
39 Intrastriatal ventral mesencephalic xenografts of porcine tissue in rats: immune responses and functional effects. Cell Transplant 2000 0.79
40 Human natural antibodies cytotoxic to pig embryonic brain cells recognize novel non-Galalpha1,3Gal-based xenoantigens. Exp Neurol 1999 0.79
41 Xenotransplantation for CNS repair: immunological barriers and strategies to overcome them. Trends Neurosci 2000 0.79
42 Neural transplantation in Parkinson's disease: the Swedish experience. Prog Brain Res 1990 0.78
43 Effects of immunosuppressive treatment on host responses against intracerebral porcine neural tissue xenografts in rats. Transplantation 2001 0.78
44 Antioxidant treatment protects striatal neurons against excitotoxic insults. Neuroscience 1996 0.78
45 Addition of allogeneic spleen cells causes rejection of intrastriatal embryonic mesencephalic allografts in the rat. Neuroscience 1997 0.78
46 Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease. Mov Disord 2000 0.77
47 Xenotransplantation. Prog Brain Res 2000 0.77
48 Differential effects of Bcl-2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurons in intracerebral transplants. Eur J Neurosci 1999 0.77
49 Can human fetal dopamine neuron grafts provide a therapy for Parkinson's disease? Prog Brain Res 1988 0.77
50 Human fetal basal forebrain neurons grafted to the denervated rat hippocampus produce an organotypic cholinergic reinnervation pattern. Brain Res 1988 0.76
51 NIH neural transplantation funding. Science 1994 0.76
52 In reply: fetal brain grafts and Parkinson's disease. Science 1990 0.76
53 Enhanced survival of porcine neural xenografts in mice lacking CD1d1, but no effect of NK1.1 depletion. Cell Transplant 2001 0.76
54 Discordant xenografts: different outcome after mouse and rat neural tissue transplantation to guinea-pigs. Brain Res Bull 1999 0.75
55 Methylprednisolone prevents rejection of intrastriatal grafts of xenogeneic embryonic neural tissue in adult rats. Brain Res 1996 0.75
56 [Acupuncture therapy in stroke. Patients experience significant improvement]. Lakartidningen 1993 0.75
57 [Pravidel may cause pulmonary changes. Signs of inflammatory activity and weight loss are part of the picture]. Lakartidningen 1994 0.75
58 Porcine embryonic brain cell cytotoxicity mediated by human natural killer cells. Cell Transplant 2000 0.75
59 Attitudes to xenotransplantation: interviews with patients suffering from parkinson's disease focusing on the conception of risk. Transplant Proc 2000 0.75
60 Tirilazad reduces brain edema after middle cerebral artery ligation in hypertensive rats. Acta Neurochir Suppl (Wien) 1994 0.75
61 Stroke incidence: circadian and circaseptan (about weekly) variations in onset. Prog Clin Biol Res 1990 0.75
62 [Patients' attitudes to xenotransplantation: "I'll do anything, I don't want to die!"]. Lakartidningen 2000 0.75
63 [Promising new results with transplantation of nerve cells to the brain in Parkinson disease]. Lakartidningen 1990 0.75
64 Immunological aspects of neural grafting in the mammalian central nervous system. Prog Brain Res 1988 0.75